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Introduction
Hypermobile kidney, also known as a  floating 
kidney, renal ptosis or nephroptosis, is a  condition 
in which the kidney descends more than 2 vertebral 
bodies (or > 5 cm) during supine to upright position 
change [1]. The kidney is capable of returning to 
a normal anatomical site, which differentiates it from 
an ectopic organ. Although the hypermobile kidney 
was first described in the 16th century by Franciscus 
de Pedemantanus, the first successful nephropexy 
was performed in 1881 [2]. The procedure was re-
fined and popularised by the American gynaecologist 
George Edebohls, who in 1893 published a series of 
12 cases [3]. Since then nearly 200 different tech-
niques of nephropexy have been described [4–8].
Although nephroptosis is a common condition, it 
remains, in the majority of cases, completely asymp-
tomatic [3]. It is often incidentally diagnosed on ra-
diological imaging for other reasons. However, up to 
10–20% of affected patients may complain of flank 
or abdominal pain aggravated by long periods in an 
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A b s t r a c t
Introduction: Symptomatic hypermobile kidney is treated with nephropexy, a surgical procedure through which the 
floating kidney is fixed to the retroperitoneum. Although both open and endoscopic procedures have a high success 
rate, they can be associated with risk of complications, relatively long hospital stay and high cost.
Aim: We describe our percutaneous technique for fixing a hypermobile kidney and evaluate the efficacy of the per-
cutaneous nephrostomy insertion in management of symptomatic nephroptosis.
Material and methods: Between January 2005 and December 2011, 11 patients diagnosed with a symptomatic right 
nephroptosis of at least 1 year duration were treated with a single point percutaneous nephrostomy technique. All 
data were retrieved from patients’ medical records and then retrospectively analysed.
Results: Nephropexy through a single point percutaneous nephrostomy technique was successfully accomplished in 
11 women. The mean operative time was 20 min. The intraoperative estimated blood loss was minimal in all cases. 
No major or minor intraoperative complications were noted. The average postoperative hospital stay was 2 days. 
Women returned to their usual activities 14 days following the surgery. Nine women had complete resolution of their 
pain, and 2 patients continued to complain of discomfort in their lumbar area. One patient was re-operated upon 
with satisfactory subjective and objective outcomes achieved. One patient refused re-operation.
Conclusions: Percutaneous nephropexy is simple, inexpensive and effective for treatment of symptomatic hypermo-
bile kidney. It remains a valuable alternative to open, laparoscopic, and robotic methods for fixing a floating kidney.
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upright position which is reduced or relieved by lying 
down [1, 3].
Symptomatic nephroptosis is treated with ne-
phropexy, a  surgical procedure through which the 
floating kidney is fixed to the retroperitoneum. This 
intervention can be performed through both open 
and endoscopic approaches [3, 5–8]. Although both 
procedures have a high success rate, they can be as-
sociated with a non-negligible risk of complications, 
relatively long hospital stay and substantial cost. 
Percutaneous nephrostomy (PCN) is a minimally in-
vasive technique, which allows for easy percutane-
ous access to the kidney, insertion of a tube into the 
ptotic organ and its subsequent stabilization [3, 9]. 
This then results in the development of fibrotic tis-
sue leading to the resolution of symptoms, and nor-
malisation of urinalysis, at the expense of minimal 
scarring [10–12]. Moreover, it simultaneously allows 
for the removal of renal stones [13, 14].
Aim
We describe our own percutaneous technique of 
fixing the hypermobile kidney, and we evaluate the 
efficacy of the percutaneous nephrostomy insertion 
in management of symptomatic nephroptosis.
Material and methods
This retrospective study was approved by the 
Departmental Review Board and all the procedures 
have been carried out in accordance with the Hel-
sinki Declaration of 1975, as revised in 1983. Elev-
en women (age 18–56 years, mean 36.8 years) di-
agnosed with right nephroptosis were treated with 
a single point percutaneous nephrostomy technique 
in the Department of Urology and Uro-oncology at 
the Medical University of Lublin, Poland between 
2005 and 2011. The body mass index averaged 
18.42  kg/m2 (range: 17.01–19.37  kg/m2). All pa-
tients had symptomatic right hypermobile kidney 
for at least 1 year duration. Preoperative intravenous 
pyelography (IVP), performed in the supine and up-
right positions, revealed a  kidney descent of more 
than 5 cm. Moreover, in 5 women, up to 1 cm large 
calcified deposits within the pelvicalyceal collecting 
system were identified on IVP. 
All patients underwent an elective nephropexy 
with percutaneous nephrostomy. The procedures 
were performed under spinal anaesthesia. The ure-
teric catheter was introduced into the ureter and the 
contrast medium (Ultravist) was then administered. 
The patients were placed in the prone position on 
the X-ray table. Under direct X-ray guidance the col-
lecting system was incised in the lower calyx. The 
nephroscope was then introduced via a routine ap-
proach. All previously identified renal calculi, if pres-
ent, were found and removed. Next, the kidney was 
pushed to the maximal upward position, and an 
18 F nephrostomy tube was inserted into the upper 
calyx. Following the procedure, as soon as a  clear 
urine outflow was obtained and no pain was report-
ed, the nephrostomy tube was closed and left in situ 
for about 4 weeks and then removed. Low-dose tri-
methoprim prophylaxis was administered daily until 
the nephrostomy tube was taken out and a  single 
intravenous dose of gentamycin was given prior to 
the nephrostomy drain removal. The follow-up IVP 
and ultrasound examination of the urinary tract 
were performed 3 months following the procedure.
Results
Nephropexy through a single point percutaneous 
nephrostomy technique was successfully accom-
plished in 11 women. The nephrostomy scar, with 
a mean length of 8 mm, healed in all patients with 
an excellent aesthetic outcome. The mean operative 
time was 20 min (range: 15–45 min). The intraoper-
ative estimated blood loss was minimal in all cas-
es. No major or minor intraoperative complications 
were noted. The average postoperative hospital stay 
was 2 days (range: 1–4 days). No urinary tract infec-
tions in the immediate postoperative period, while 
the nephrostomy tube was left in situ, and after ne-
phrostomy tube removal, were noted. The mean fol-
low-up was 12 months (range: 3–36 months). Wom-
en returned to their usual activities 14 days (range: 
10–28 days) following the surgery. Nine women had 
complete resolution of the pain, and 2 patients con-
tinued to complain of lumbar discomfort. 
The follow-up ultrasound examination of the uri-
nary tract showed no signs of obstruction or stones 
within the collecting system. The repeated IVP con-
firmed complete resolution of nephroptosis in 
9 women, while unchanged findings, similar to those 
prior to surgery, were found in 2 cases. One patient 
was re-operated with satisfactory subjective (symp-
tom-free) and objective (IVP confirmed) outcomes 
achieved. One patient refused re-operation. She is 
regularly followed up and currently remains pain free, 
with only occasionally abnormal urinalysis results 
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which, in case of associated dysuria, are successfully 
treated with anti-inflammatory medications. 
Discussion
The exact cause of nephroptosis remains un-
known. Symptomatic patients, however, exhibit 
a few common features [1]. Typically, patients with 
nephroptosis are represented by thin females [1–3]. 
It has been hypothesized, therefore, that the ab-
sence of perirenal fat and fascial support could lead 
to the downward translocation of the kidney. In 
addition, patients with nephroptosis often present 
with a  longer-than-normal renal vascular pedicle, 
which allows for renal displacement in the sagittal 
and frontal axes [15]. Treatment of nephropexy is 
reserved for symptomatic patients only [3, 12]. The 
surgery can be performed through either an open 
or endoscopic approach [3]. In addition, transperi-
toneal laparoscopic-robotic-assisted technique has 
also been described [4–8]. Although approximately 
200 techniques of nephropexy have been reported, 
and the majority of the procedures have a high suc-
cess rate, they can be associated with a significant 
risk of complications, relatively long hospital stay 
and a significant cost [3, 4].
In our case series, 11 women underwent a sin-
gle point percutaneous nephrostomy nephropexy 
for symptomatic hypermobile kidney. The procedure 
was successful in 9 patients, and was associated 
with minimal discomfort, as well as a short hospital 
stay. No major or minor intraoperative complications 
were observed. Moreover, in 5 women it allowed for 
synchronous and complete removal of renal stones. 
Various authors have reported their experience with 
percutaneous nephrostomy techniques [10, 12, 13, 
16]. A  two-point percutaneous method was de-
scribed by Elashry which involved placing a nephros-
tomy tube for 14 days [12]. The average operative 
time was 22 min and the mean hospital stay was 
3 days. There were no intraoperative complications, 
and there was an overall 85% success rate. Interest-
ingly, a similar technique with simultaneous nephro-
lithotomy and endopyelotomy during a  single ses-
sion, with the same outcome, has been previously 
reported [13]. 
The single point percutaneous technique has 
been described mostly in relation to planned percu-
taneous nephrolithotomy in a floating kidney, and it 
has been associated with a high success rate [10]. 
Similarly, our success rate was high (81% for sin-
gle session and 90% for two-session treatments). 
Although the applied percutaneous technique of 
kidney immobilisation at a more cephalad position, 
and the consequent relief of urinary obstruction as-
sociated with nephroptosis, caused nephrostomy-re-
lated discomfort, it was of minimal significance to 
our patients, and none of the women perceived it 
as a major drawback of the treatment. Two patients 
failed percutaneous nephropexy at the first attempt. 
In our opinion, there were likely two reasons for 
this. Firstly, the kidney was placed too low before 
the nephrostomy was attempted, and secondly, the 
nephrostomy was kept in situ for too short a time. 
Those patients were offered a second PCN. The re-
peated single point percutaneous technique was 
successful in one woman, while the other refused 
further invasive treatment.
Although we have observed no complications 
during and following a single point percutaneous ne-
phrostomy nephropexy procedure for symptomatic 
hypermobile kidney, several studies have reported 
a  number of peri- and postoperative morbidities 
associated with radiologically guided percutaneous 
nephrostomy insertion for the treatment of both 
dilated and non-dilated kidney collecting system 
conditions [17–19]. The most serious complication 
of PCN insertion is sepsis [17]. Its frequency of 1.3% 
has been reported in patients without kidney stones 
and dramatically increased in those with pyone-
phrosis [20]. To prevent septic episodes we admin-
istered peri-procedural antibiotic prophylaxis (a sin-
gle intravenous dose of gentamicin) to our patients. 
Moreover, to further reduce the risk of postoperative 
urinary tract infection, a  low dose of trimethoprim 
prophylaxis was given daily until a  nephrostomy 
tube was taken out and a single intravenous dose 
of gentamycin was given prior to nephrostomy drain 
removal.
Bleeding is the most common local complication 
of PCN insertion. Although in most cases blood loss 
is minor, blood transfusion may be required in up 
to 4% of patients undergoing standard nephrosto-
my insertion and up to 27% in cases of nephrolitho-
tomy, where larger instruments are used [17, 19]. 
Coagulopathy has been identified as an important 
factor affecting the severity and frequency of bleed-
ing requiring blood transfusion, with lower rates 
(2%) of transfusion-dependent blood loss occurring 
in non-coagulopathic patients [20]. None of our pa-
tients had a  history of coagulopathy disorder and 
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all women had a normal coagulation screen prior to 
the PCN procedure. In our study, we observed mi-
nor intraoperative blood loss (approximately 30 ml) 
and no bleeding following surgery. The low degree of 
bleeding in our patients can also be attributed to the 
broad experience of urologists performing percuta-
neous nephrostomy insertion, as well as the fact that 
in most of our cases we used instruments smaller 
than 30 F.
Bowel transgression and pneumothorax are rare, 
yet serious complications of the PCN procedure. Ret-
rorenal colon has been identified as a risk factor for 
intestinal injury, whereas complex endo-urological 
procedures requiring access to the upper calyx of the 
normally placed kidney increase the risk of pleural 
injury [17, 20]. None of our patients have suffered 
these complications. We ruled out the presence of 
retrorenal intestine using an ultrasound examina-
tion performed immediately prior to the PCN inser-
tion procedure. As the aim of our treatment was to 
fix a ptotic kidney, we approached the lower calyx 
and did not need to use the intercostal access, re-
ducing, therefore, the risk of pleural injury.
One of the most important advantages of the 
percutaneous procedure is its simplicity, and also the 
ability to remove kidney stones during the same ses-
sion. This makes the treatment minimally invasive 
and gives excellent long-term outcomes. The fol-
low-up observations are very reassuring, and, there-
fore, this method remains, in our department, the 
preferred treatment option of symptomatic patients 
with floating kidney. 
Conclusions
Percutaneous nephropexy is a  simple, inexpen-
sive and effective method of treatment for symp-
tomatic hypermobile kidney. In addition to excel-
lent kidney immobilization, this minimally invasive 
method allowed for simultaneous complete removal 
of renal stones. Percutaneous nephropexy remains, 
therefore, an important alternative to open, laparo-
scopic, and robotic methods for fixing a hypermobile 
kidney.
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